NCT00377442View on ClinicalTrials.gov

A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

GK Activator (2)

100mg po

DRUG

Simvastatin

80mg po

Trial Locations (2)

78229

San Antonio

98418

Tacoma

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00377442 - A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes. | Biotech Hunter | Biotech Hunter